You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Prevalence of advanced HIV disease

From: Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa

  N (%)
All subjectsa, median CD4 cell count (range) 185 (1–1541)
 HIV-1 infectedb, median CD4 cell count (range) 170 (1–1541)*
 HIV-2 infected, median CD4 cell count (range) 412 (9–1005)*
CD4 cell count categories
  ≤ 350 cells/mm3 135 (73.0)
  < 200 cells/mm3 102 (55.1)
  < 100 cells/mm3 67 (36.2)
  < 50 cells/mm3 36 (19.5)
WHO stage 3 or 4c 89 (53.3)
 Stage 3 conditions
  Severe weight loss 35 (21.2)
  Chronic diarrhea 29 (17.6)
  Oral candidiasis 28 (17.0)
  Oral hairy leukoplakia 5 (3.0)
  Pulmonary TB 19 (13.1)
  Severe bacterial infections 5 (3.0)
 Stage 4 conditions
  Wasting 6 (3.6)
  PCP 2 (1.2)
  Recurrent severe bacterial PNA 2 (1.2)
  Esophageal candidiasis 6 (3.6)
  Extrapulmonary TB 12 (7.3)
  Kaposi sarcoma (cutaneous) 3 (1.8)
  Toxoplasmosis 1 (0.6)
  Extrapulmonary cryptococcosis 2 (1.2)
  Invasive cervical carcinoma 1 (0.6)
CD4 count < 200 cells/mm3 or WHO stage 3 or 4d 123 (71.1)
  1. *The difference in CD4 cell counts was statistically significant, p-value = 0.03
  2. aCD4 cell counts available for 185 subjects
  3. bIncludes 2 dually infected subjects
  4. cWHO stage available for 167 subjects; Specific WHO stage 3 or 4 conditions available for 165 subjects
  5. dData available for 173 subjects